Validation of the Accuracy of an AI-Based System for Diagnosing Anxiety Disorders
ConditionAnxiety Disorders
Trial statusNot yet recruiting
Trial phaseNot listed
Trial typeObservational
Biological sexAll
Age18-60
SponsorShanghai Mental Health Center
About this trial
The trial aimed to evaluate the efficacy of an artificial intelligence-based system for diagnosing anxiety disorders. Specifically, it sought to determine whether the system's assessment validity is non-inferior to that of psychiatric specialists.
Eligibility criteria
Qualifiers
Subjects with anxiety disorders
In accordance with ICD-11 for Anxiety Disorders;
Between the ages of 18-60;
Ability to use computers or smartphone;
Disqualifiers
With severe psychiatric symptoms requiring hospitalization, or unable to complete the required assessment and treatment;
With a high risk of suicide or self-injury;
With severe physical diseases, central nervous system diseases, or substance abuse;
With intellectual, visual, or auditory impairments that affect their ability to interact with aided-diagnostic systems.
Trial design
Treatments tested in this trial
- Not listed
Trial groups
No trial groups listed
Sponsors and collaborators
Source ClinicalTrials.gov